COMMUNIQUÉS West-GlobeNewswire
-
Reunion Neuroscience Announces Appointment of Sahil V. Kirpekar, M.D., as President and CEO
15/06/2026 -
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
15/06/2026 -
Immuneering Appoints Andrew Gengos as Chief Financial Officer
15/06/2026 -
10 Barrel Brewing and Pub Beer Kick Off Pacific Northwest Summer of Soccer Celebration
15/06/2026 -
Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
15/06/2026 -
HPSA and Circular Materials Launch Joint Consumer Education Initiative to Improve Recycling Across Ontario and New Brunswick
15/06/2026 -
L’ARPS et Circular Materials lancent une initiative conjointe de sensibilisation des consommateurs pour améliorer le recyclage en Ontario et au Nouveau-Brunswick
15/06/2026 -
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
15/06/2026 -
DOGECOIN CASH FILES UTILITY PATENT FOR BLOCKCHAIN INFRASTRUCTURE DESIGNED TO SUPPORT DOGECOIN APPLICATION USABILITY
15/06/2026 -
ENA Respiratory Receives USPTO Notice of Allowance for Two Patents Covering TLR2 Agonists and Rhinovirus-Mediated COPD Exacerbations
15/06/2026 -
Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors
15/06/2026 -
KFSH Presents Applied Radiology AI Model at HLTH Europe 2026
15/06/2026 -
KFSH présente un modèle d’IA appliquée au HLTH Europe 2026
15/06/2026 -
EURneffy 1 mg approved in the UK as the first and only needle-free adrenaline treatment for young children (aged 4 and older, 15–30 kg) at risk of anaphylaxis
15/06/2026 -
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
15/06/2026 -
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
15/06/2026 -
Enterome presents Phase 1/2 iNHL interim data at EHA demonstrating durable OncoMimics™-induced CD8 T cell responses and clinical activity
15/06/2026 -
Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development
15/06/2026 -
Intravacc et SynphaBase annoncent un partenariat stratégique visant à faire progresser le développement des vaccins conjugués
15/06/2026
Pages